SEC Form 4 · accession 0001127602-16-043951
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David P Johst
Officer — Corporate Executive VP
Period of report
Feb 25, 2016
Accepted (ET)
Feb 29, 2016 · 5:47 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001100682
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 25, 2016 | M | 34,075 | $24.80 | A | 189,023 | D | |
| Common Stock | Feb 25, 2016 | S | 30,020 | $73.00 | D | 159,003 | D | |
| Common Stock | Feb 25, 2016 | S | 100 | $73.02 | D | 158,903 | D | |
| Common Stock | Feb 25, 2016 | S | 100 | $73.05 | D | 158,803 | D | |
| Common Stock | Feb 25, 2016 | S | 100 | $73.06 | D | 158,703 | D | |
| Common Stock | Feb 25, 2016 | S | 100 | $73.07 | D | 158,603 | D | |
| Common Stock | Feb 25, 2016 | S | 200 | $73.08 | D | 158,403 | D | |
| Common Stock | Feb 25, 2016 | S | 100 | $73.10 | D | 158,303 | D | |
| Common Stock | Feb 25, 2016 | S | 100 | $73.11 | D | 158,203 | D | |
| Common Stock | Feb 25, 2016 | S | 790 | $73.12 | D | 157,413 | D | |
| Common Stock | Feb 25, 2016 | S | 100 | $73.14 | D | 157,313 | D | |
| Common Stock | Feb 25, 2016 | S | 100 | $73.15 | D | 157,213 | D | |
| Common Stock | Feb 25, 2016 | S | 200 | $73.16 | D | 157,013 | D | |
| Common Stock | Feb 25, 2016 | S | 200 | $73.18 | D | 156,813 | D | |
| Common Stock | Feb 25, 2016 | S | 400 | $73.20 | D | 156,413 | D | |
| Common Stock | Feb 25, 2016 | S | 100 | $73.21 | D | 156,313 | D | |
| Common Stock | Feb 25, 2016 | S | 400 | $73.23 | D | 155,913 | D | |
| Common Stock | Feb 25, 2016 | S | 100 | $73.2315 | D | 155,813 | D | |
| Common Stock | Feb 25, 2016 | S | 100 | $73.232 | D | 155,713 | D | |
| Common Stock | Feb 25, 2016 | S | 100 | $73.234 | D | 155,613 | D | |
| Common Stock | Feb 25, 2016 | S | 665 | $73.24 | D | 154,948 | D | |
| Common StockF1 | Feb 26, 2016 | A | 1,366 | $0.00 | A | 156,314 | D | |
| Common StockF2 | Feb 26, 2016 | A | 6,553 | $0.00 | A | 162,867 | D | |
| Common Stock | Feb 27, 2016 | F | 987 | $73.70 | D | 161,880 | D | |
| Common Stock | Feb 28, 2016 | F | 1,134 | $73.70 | D | 160,746 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy) | $24.80 | Feb 25, 2016 | M | 34,075 | D | Feb 27, 2010 | Feb 27, 2016 | Common Stock | 34,075 | 0 | D |
| Stock Options (Right to Buy)F3 | $73.70 | Feb 26, 2016 | A | 32,158 | A | Feb 26, 2017 | Feb 26, 2021 | Common Stock | 32,158 | 32,158 | D |
Explanation of responses
- F1Consists of 1,366 unvested restricted stock units that vest equally over two (2) years beginning one (1) year from the date of issuance.
- F2Consists of 6,553 unvested restricted stock units that vest as follows: 1,638 shares vest one (1) year from the date of issuance, 1,638 shares vest two (2) years from the date of issuance, 1,638 shares vest three (3) years from the date of issuance, and 1,639 shares vest four (4) years from the date of issuance.
- F3Stock options vest as follows: 8,039 options vest one (1) year from the date of grant, 8,040 options vest two (2) years from the date of grant, 8,039 options vest three (3) years from the date of grant, and 8,040 options vest four (4) years from the date of grant.